Octreotide can control lymphorrhea after axillary node dissection in mastectomy operations.
Mahmoud
Sabry A
SA
Abdel-Elah
Kamal
K
Eldesoky
Abdel-Hamid
AH
El-Awady
Saleh I
SI
D000328:Adult; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001365:Axilla; D001943:Breast Neoplasms / Q000601:surgery*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008197:Lymph Node Excision / Q000009:adverse effects*; D008206:Lymphatic Diseases / Q000188:drug therapy* / Q000209:etiology; D008408:Mastectomy; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide